Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 552.74 | 82.05 | 69.01 | 171.08 |
Short Term Investments | 283.52 | 472.72 | 361.94 | 235.92 |
Cashand Short Term Investments | 836.26 | 643.64 | 508.71 | 467.50 |
Accounts Receivable- Trade Net | 542.72 | 419.58 | 332.40 | 287.80 |
Total Receivables Net | 542.72 | 562.58 | 437.05 | 386.69 |
Total Inventory | 363.04 | 288.22 | 227.31 | 179.00 |
Other Current Assets Total | 150.19 | 60.02 | 124.75 | 2.61 |
Total Current Assets | 1,892.21 | 1,554.46 | 1,297.82 | 1,035.81 |
Property/ Plant/ Equipment Total- Net | 556.76 | 489.35 | 293.45 | 311.93 |
Intangibles Net | 12.52 | 8.40 | 10.80 | 7.24 |
Long Term Investments | 150.24 | 70.91 | 63.24 | 0.66 |
Note Receivable- Long Term | 11.13 | 3.49 | - | 1.80 |
Other Long Term Assets Total | 74.52 | 62.02 | 70.96 | 6.12 |
Total Assets | 2,697.38 | 2,191.40 | 1,736.32 | 1,363.61 |
Accounts Payable | 209.41 | 164.37 | 163.18 | 88.50 |
Accrued Expenses | 10.36 | 8.47 | 9.80 | 6.10 |
Current Portof LT Debt/ Capital Leases | 1.05 | 4.55 | 0.96 | 17.86 |
Other Currentliabilities Total | 109.74 | 90.61 | 33.74 | 30.39 |
Total Current Liabilities | 330.56 | 268.00 | 207.68 | 142.85 |
Capital Lease Obligations | 0.92 | 0.93 | 1.17 | 0.53 |
Total Long Term Debt | 0.92 | 0.93 | 1.17 | 0.53 |
Total Debt | 1.97 | 5.48 | 2.13 | 18.39 |
Deferred Income Tax | 0.00 | - | 2.42 | 1.49 |
Minority Interest | 31.12 | 26.79 | 25.95 | 17.54 |
Other Liabilities Total | 19.08 | 15.20 | 15.17 | 15.37 |
Total Liabilities | 381.68 | 310.92 | 252.39 | 177.79 |
Common Stock Total | 15.19 | 15.18 | 15.16 | 15.13 |
Retained Earnings( Accumulated Deficit) | 2,225.93 | 1,554.29 | 1,205.49 | 928.56 |
Unrealized Gain( Loss) | 74.58 | 74.58 | 74.58 | - |
Total Equity | 2,315.70 | 1,880.48 | 1,483.93 | 1,185.82 |
Total Liabilities Shareholders' Equity | 2,697.38 | 2,191.40 | 1,736.32 | 1,363.61 |
Total Common Shares Outstanding | 7.59 | 7.59 | 7.58 | 7.56 |
Tangible Book Valueper Share Common Eq | 303.28 | 246.28 | 194.37 | 155.80 |
Cash | - | 88.87 | 77.76 | 60.50 |
Property/ Plant/ Equipment Total- Gross | - | 682.23 | 447.22 | 425.47 |
Accumulated Depreciation Total | - | -192.88 | -153.79 | -113.54 |
Goodwill Net | - | 2.77 | 0.05 | 0.05 |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 0.00 |
Additional Paid- In Capital | - | 13.41 | 14.63 | 2.12 |
ESOP Debt Guarantee | - | 15.37 | 8.95 | 14.80 |
Other Equity Total | - | 207.65 | 165.12 | 225.21 |
Long Term Debt | - | - | - | 0.00 |
Caplin Point Laboratories Dividend Caplin Point Laboratories Bonus Caplin Point Laboratories News Caplin Point Laboratories AGM Caplin Point Laboratories Rights Caplin Point Laboratories Splits Caplin Point Laboratories Board Meetings Caplin Point Laboratories Key Metrics Caplin Point Laboratories Shareholdings Caplin Point Laboratories Profit Loss Caplin Point Laboratories Cashflow Caplin Point Laboratories Q1 Results Caplin Point Laboratories Q2 Results Caplin Point Laboratories Q3 Results Caplin Point Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks